Distal Biliary Malignancy

Surgical Clinics of North America

Volumn 88, Issue 6, 2008, Pages 1429-1447

  Veillette, Gregory ^a   Castillo, Carlos Fernández del ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; THORIUM DIOXIDE;

ADENOCARCINOMA; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMMON BILE DUCT CYST; CYSTIC DUCT; DIAGNOSTIC IMAGING; FASCIOLIASIS; HISTOPATHOLOGY; HUMAN; JAUNDICE; PALLIATIVE THERAPY; PANCREATICODUODENECTOMY; PAPILLOMATOSIS; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STENT; VATER PAPILLA;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; HUMANS; PROGNOSIS;

EID: 55049125050     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.07.003     Document Type: Review

References (67)

1. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38 (1965) 241-256
2. Bismuth H., Nakache R., and Diomond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215 1 (1992) 31-38
3. Tompkins R.K., Thomas D., Wile A., et al. Prognostic factors in bile duct carcinoma. Analysis of 96 cases. Ann Surg 194 (1981) 447-457
4. Reding R., Buard J.L., Lebeau G., et al. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded): results of the French Surgical Association survey. Ann Surg 213 3 (1991) 236-241
5. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473 [discussion: 473-5]
6. Shaib Y., and El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 24 (2004) 115-125
7. Khan S.A., Taylor-Robinson S.D., Toledano M.B., et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumors. J Hepatol 37 (2002) 806-813
8. Weinbren K., and Mutum S.S. Pathological aspects of cholangiocarcinoma. J Pathol 139 (1983) 217-238
9. Kozuka S., Tsubone M., and Hachisuka K. Evolution of carcinoma in the extrahepatic bile ducts. Cancer 54 (1984) 65-72
10. Fevery J., Verslype C., Lai G., et al. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci 52 (2007) 3123-3135
11. Ahrendt S.A., Nakeeb A., and Pitt H.A. Cholangiocarcinoma. Clin Liver Dis 5 1 (2001) 191-218
12. Broome U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 4 (1996) 610-615
13. Jarnagin W.R. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 19 (2000) 156-176
14. Bergquist A., Ekbom A., Olsson R., et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36 (2002) 321-327
15. Rosen C.B., Nagorney D.M., Wiesner R.H., et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213 1 (1991) 21-25
16. Iwai N., Yanagihara J., Tokiwa K., et al. Congenital choledochal dilatation with emphasis on pathophysiology of the biliary tract. Ann Surg 215 1 (1992) 27-30
17. Stain S.C., Guthrie C.R., Yellin A.E., et al. Choledochal cyst in the adult. Ann Surg 222 2 (1995) 128-133
18. Liu C.L., Fan S.T., Lo C.M., et al. Choledochal cysts in adults. Arch Surg 137 (2002) 465-468
19. Watanapa P., and Watanapa W.B. Liver fluke-associated cholangiocarcinoma. Br J Surg 89 (2002) 962-970
20. Nishimura M., Naka S., Hanazawa K., et al. Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis. Dig Dis Sci 50 11 (2005) 2153-2158
21. Sheen-Chen S.M., Chou F.F., and Eng H.L. Intrahepatic cholangiocarcinoma in hepatolithiasis: a frequently overlooked disease. J Surg Oncol 47 2 (1991) 131-135
22. Chen P.H., Lo H.W., Wang C.S., et al. Cholangiocarcinoma in hepatolithiasis. J Clin Gastroenterol 6 6 (1984) 539-547
23. Sahani D., Prasad S.R., Tanabe K.K., et al. Thorotrast-induced cholangiocarcinoma: case report. Abdom Imaging 28 (2003) 72-74
24. Khan S.A., Thomas H.C., Davidson B.R., et al. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
25. Lee S.S., Kim M.H., Lee S.K., et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer 100 4 (2004) 783-793
26. Lazaridis K.N., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655-1667
27. Sirica A.E. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41 1 (2005) 5-15
28. Malhi H., and Gores G.J. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45 (2006) 856-867
29. Berthiaume E.P., and Wands J. The molecular pathogenesis of cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 127-137
30. Jarnagin W.R., Klimstra D.S., Hezel M., et al. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24 7 (2006) 1152-1160
31. Nehls O., Gregor M., and Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 139-154
32. Lindberg B., Arnelo U., Bergquist A., et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreatography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 34 (2002) 909-916
33. Chalasani N., Baluyut A., Ismail A., et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31 1 (2000) 7-11
34. Nichols J.C., Gores G.J., LaRusso N.F., et al. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68 9 (1993) 874-879
35. Patel A.H., Harnois D.M., Klee G.G., et al. The utility of CA 19-9 in the diagnosis of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 95 1 (2000) 204-207
36. Siqueira E., Schoen R., Silverman W., et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 56 1 (2002) 40-47
37. Bjornsson E., Kilander A., and Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 19 6 (1999) 501-508
38. Ramage J.K., Donaghy A., Farrant J.M., et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108 (1995) 865-869
39. Rumalla A., Baron T.H., Leontovich O., et al. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc 76 1 (2001) 29-33
40. Kipp B.R., Stadheim L.M., Halling S.A., et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 99 (2004) 1675-1681
41. American Joint Committee on Cancer. AJCC cancer staging (2005), Springer-Verlag, New York p. 1-150
42. Ebata T., Nagino M., Nishio H., et al. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American joint committee on cancer. World J Surg 31 (2007) 2008-2015
43. Slattery J.M., and Sahani D.V. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?. Oncologist 11 (2006) 913-922
44. Walsh R.M., Connelly M., and Baker M. Imaging for the diagnosis and staging of periampullary carcinomas. Surg Endosc 17 (2003) 1514-1520
45. Eloubeidi M.A., Chen V.K., Jhala N.C., et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2 (2004) 209-213
46. Aranha G.V., Aaron J.M., Shoup M., et al. Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery 140 (2006) 561-569
47. Muscari F., Suc B., Kirzin S., et al. Risk factors for mortality and intra-abdominal complications after pancreaticoduodenectomy: multivariate analysis in 300 patients. Surgery 139 (2005) 591-598
48. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226 (1997) 248-257
49. Warren K.W., Choe D.S., Plaza J., et al. Results of radical resection for periampullary cancer. Ann Surg 181 (1975) 534-540
50. Nakase A., Matsumoto Y., Uchida K., et al. Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan. Ann Surg 185 (1977) 52-57
51. Lerut J.P., Gianello P.R., Otte J.B., et al. Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients. Ann Surg 199 (1984) 432-437
52. Fong Y., Blumgart L.H., Lin E., et al. Outcome of treatment for distal bile duct cancer. Br J Surg 83 12 (1996) 1712-1715
53. Wade T.P., Prasad C.N., Virgo K.S., et al. Experience with distal bile duct cancers in U.S. veterans affairs hospitals: 1987-1991. J Surg Oncol 64 (1997) 242-245
54. Bortolasi L., Burgart L.J., Tsiotos G.G., et al. Adenocarcinoma of the distal bile duct: a clinicopathologic outcome analysis after curative resection. Dig Surg 17 (2000) 36-41
55. Yoshida T., Matsumoto T., Sasaki A., et al. Prognostic factors after pancreaticoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 137 (2002) 69-73
56. Murakami Y., Uemura K., Hayashidani Y., et al. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol 95 (2007) 207-212
57. Cheng Q., Luo X., Zhang B., et al. Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 14 3 (2007) 1212-1219
58. DeOliveira M.L., Cunningham S.C., Cameron J.L., et al. Cholangiocarcinoma: thirty-one year experience with 564 patients at a single institution. Ann Surg 245 5 (2007) 755-762
59. Whipple A.O., Parsons W.B., and Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 102 4 (1935) 763-779
60. Balcom J.H., Rattner D.W., Warshaw A.L., et al. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136 (2001) 391-398
61. Yeo C.J., Cameron J.L., Maher M.M., et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222 (1995) 580-588
62. Pratt W.B., Maithel S.K., Vanounou T., et al. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) classification scheme. Ann Surg 245 (2007) 443-451
63. Kazanjian K.K., Hines O.J., Eibl G., et al. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg 140 (2005) 849-855
64. Veillette G.R., Dominguez I., Ferrone C., et al. Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the MGH experience. Arch Surg 143 5 (2008) 476-481
65. Sewkani A., Kapoor S., Sharma S., et al. Squamous cell carcinoma of the distal common bile duct. JOP 6 2 (2005) 162-165
66. Podnos Y.D., Jimenez J.C., Zainabadi K., et al. Carcinoid tumors of the common bile duct: report of two cases. Surg Today 33 7 (2003) 553-555
67. Nagai E., Shinohara M., Yonemasu H., et al. Undifferentiated carcinoma of the common bile duct: case report and review of the literature. J Hepatobiliary Pancreat Surg 9 (2002) 627-631